Verrica Pharmaceuticals Inc.
VRCA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001660334
In the last 90 days, Verrica Pharmaceuticals Inc. insiders filed 4 open-market purchases and 0 sales; 43 institutions reported holding it in 13F filings for Q2 2026, worth $28.5M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Verrica Pharmaceuticals Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 4 filings
- 4 insiders, $210.9K in total
- Open-market sells
- 0 filings
- Insiders trading
- 4
- Net value
- +$210.9K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Verrica Pharmaceuticals Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Zawitz David | Chief Operating Officer | 27,000 | Aug 18, 2026 | 3 |
| Rosenberg Noah L. | CMO | 8,587 | Aug 18, 2026 | 3 |
| Rieger Jayson | CEO and President | 207,593 | Aug 18, 2026 | 3 |
| Kirby John J. | Interim CFO | 23,962 | Aug 18, 2026 | 3 |
| Prygocki Mark A Sr | Director | – | Jun 9, 2026 | 1 |
| Corcoran Gavin | Director | – | Jun 9, 2026 | 1 |
| Nguyen Diem | Director | – | Jun 9, 2026 | 1 |
| Eichenfield Lawrence | Director | – | Jun 9, 2026 | 1 |
| Manning Paul B | Director, 10% Owner | 3,348,372Indirect | Nov 25, 2025 | 1 |
| Hayes Christopher G. | CHIEF LEGAL OFFICER | 176,458 | Mar 18, 2025 | 0 |
| Goldenberg Gary | Chief Medical Officer | 120,110 | Feb 6, 2025 | 0 |
| White Ted | PRESIDENT AND CEO | 278,789 | Feb 6, 2025 | 0 |
| Bonaccorso Joe | CHIEF COMMERCIAL OFFICER | 187,738 | Feb 6, 2025 | 0 |
| Kohler Terry | CHIEF FINANCIAL OFFICER | 125,000 | Feb 6, 2025 | 0 |
| Stalfort John A III | Director | 1,873,800 | Nov 26, 2024 | 0 |
| Ballaron Craig | Director | – | Jun 7, 2024 | 0 |
| Edelman Joseph | 10% Owner | 7,099,182Indirect | Dec 29, 2023 | 0 |
| Perceptive Advisors LLC | 10% Owner | 7,099,182Indirect | Dec 29, 2023 | 0 |
| Perceptive Life Sciences Master Fund Ltd | 10% Owner | 7,099,182Indirect | Dec 29, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 25, 2025 (view filing) | Nov 25 | Same day | Zawitz DavidChief Operating Officer | PPurchase | +2.50K | – | – | –2.50K after | Derivative |
| Aug 18, 2026 (view filing)5:00 PM ET | Aug 18 | Same day | Kirby John J.Interim CFO | PPurchase | +5.00K | $4.93 | +$24.6K | +26.4%24.0K after | |
| Aug 18, 2026 (view filing)5:00 PM ET | Aug 17-18 | 1 day | Rosenberg Noah L.CMO | PPurchase | +6.23K | $4.91 | +$30.6K | +264.3%8.59K after | 2 lots |
| Aug 18, 2026 (view filing)5:00 PM ET | Aug 14-17 | 4 days | Rieger JaysonCEO and President | PPurchase | +25.0K | $5.03 | +$125.8K | +13.7%207.6K after | 2 lots |
| Aug 18, 2026 (view filing)5:00 PM ET | Aug 17 | 1 day | Zawitz DavidChief Operating Officer | PPurchase | +6.00K | $4.98 | +$29.9K | +28.6%27.0K after |